Figshareopen access
Patient-reported outcome data from a randomized phase II study (STARLIGHT) of fezolinetant in women in Japan with vasomotor symptoms associated with menopause
medicine, physiology, pharmacology, biotechnology, immunology, cancer, science policy, mental health
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 205368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.